CCDC125

gene
On this page

Also known as KENAE

Summary

CCDC125 (coiled-coil domain containing 125, HGNC:28924) is a protein-coding gene on chromosome 5q13.2, encoding Coiled-coil domain-containing protein 125 (Q86Z20). May be involved in the regulation of cell migration.

Enables identical protein binding activity. Involved in activation of GTPase activity; negative regulation of Rho protein signal transduction; and negative regulation of cell motility. Located in cytoplasm.

Source: NCBI Gene 202243 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 88 total — 1 likely-pathogenic
  • MANE Select transcript: NM_176816

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28924
Approved symbolCCDC125
Namecoiled-coil domain containing 125
Location5q13.2
Locus typegene with protein product
StatusApproved
AliasesKENAE
Ensembl geneENSG00000183323
Ensembl biotypeprotein_coding
OMIM613781
Entrez202243

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 7 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000383374, ENST00000396496, ENST00000396499, ENST00000460090, ENST00000511257, ENST00000512045, ENST00000513172, ENST00000877999, ENST00000878000, ENST00000878001

RefSeq mRNA: 3 — MANE Select: NM_176816 NM_001297696, NM_001297697, NM_176816

CCDS: CCDS4000, CCDS75255

Canonical transcript exons

ENST00000396496 — 12 exons

ExonStartEnd
ENSE000012937126929218869292362
ENSE000014965336933264969332801
ENSE000016482276930384769303929
ENSE000016586126930795169308028
ENSE000017467876930681769306902
ENSE000020218126928017569283034
ENSE000035335956929479369294900
ENSE000035722176928533769285467
ENSE000035745526931398569314046
ENSE000035797676930001269300127
ENSE000035982556932023769320580
ENSE000036259366931111869311204

Expression profiles

Bgee: expression breadth ubiquitous, 180 present calls, max score 87.78.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.0120 / max 54.2742, expressed in 1241 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
620153.01201241

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
bone marrow cellCL:000209287.78gold quality
oviduct epitheliumUBERON:000480483.36gold quality
right uterine tubeUBERON:000130283.30gold quality
right lobe of liverUBERON:000111482.52gold quality
bone marrowUBERON:000237181.14gold quality
olfactory segment of nasal mucosaUBERON:000538680.88gold quality
bronchial epithelial cellCL:000232880.72gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.58gold quality
monocyteCL:000057680.50gold quality
rectumUBERON:000105280.36gold quality
leukocyteCL:000073880.20gold quality
buccal mucosa cellCL:000233680.15silver quality
calcaneal tendonUBERON:000370179.45gold quality
bronchusUBERON:000218579.08gold quality
islet of LangerhansUBERON:000000678.62gold quality
tendonUBERON:000004378.19gold quality
mucosa of transverse colonUBERON:000499177.58gold quality
liverUBERON:000210777.52gold quality
bloodUBERON:000017877.26gold quality
stromal cell of endometriumCL:000225577.15gold quality
tendon of biceps brachiiUBERON:000818877.12gold quality
gall bladderUBERON:000211077.09gold quality
minor salivary glandUBERON:000183076.63gold quality
lower esophagus mucosaUBERON:003583476.20gold quality
body of pancreasUBERON:000115076.05gold quality
fallopian tubeUBERON:000388975.92gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099175.81gold quality
prostate glandUBERON:000236775.74gold quality
pancreasUBERON:000126475.72gold quality
right adrenal glandUBERON:000123375.18gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.69

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

60 targeting CCDC125, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-5692A100.0074.406850
HSA-MIR-428299.9975.366408
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-806399.9169.763146
HSA-MIR-380-3P99.8970.181978
HSA-MIR-153-5P99.8973.866317
HSA-MIR-449699.8868.892236
HSA-MIR-129-5P99.8870.263273
HSA-MIR-182-5P99.8774.032589
HSA-MIR-579-3P99.8671.663628
HSA-MIR-383-3P99.8565.841359
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-57799.7869.132479
HSA-MIR-6885-3P99.7570.363187
HSA-MIR-447099.6669.351767
HSA-MIR-182799.6368.573265
HSA-MIR-24-3P99.5969.971934
HSA-MIR-106A-3P99.5367.58995

Literature-anchored findings (GeneRIF, showing 1)

  • These results suggest that the novel gene, Kenae/CCDC125, acts as a regulator of cell motility through RhoA, Rac1 and cdc42. (PMID:19787194)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCcdc125ENSMUSG00000048924
rattus_norvegicusCcdc125ENSRNOG00000027410

Protein

Protein identifiers

Coiled-coil domain-containing protein 125Q86Z20 (reviewed: Q86Z20)

Alternative names: Protein kenae

All UniProt accessions (2): Q86Z20, F8W912

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in the regulation of cell migration.

Subcellular location. Cytoplasm.

Isoforms (2)

UniProt IDNamesCanonical?
Q86Z20-11, Kenae-1yes
Q86Z20-22, Kenae-2

RefSeq proteins (3): NP_001284625, NP_001284626, NP_789786* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR034608CCDC125Family

UniProt features (10 total): compositionally biased region 3, coiled-coil region 2, chain 1, region of interest 1, modified residue 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86Z20-F167.240.32

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 504

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 100 (showing top): GOBP_ACTIVATION_OF_GTPASE_ACTIVITY, GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, GOBP_REGULATION_OF_GTPASE_ACTIVITY, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, TAL1ALPHAE47_01, GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, GOBP_REGULATION_OF_HYDROLASE_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION, BROWN_MYELOID_CELL_DEVELOPMENT_UP, GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, ZHAN_MULTIPLE_MYELOMA_CD1_DN

GO Biological Process (4): negative regulation of Rho protein signal transduction (GO:0035024), activation of GTPase activity (GO:0090630), negative regulation of cell motility (GO:2000146), regulation of cell motility (GO:2000145)

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell motility2
Rho protein signal transduction1
regulation of Rho protein signal transduction1
negative regulation of small GTPase mediated signal transduction1
positive regulation of GTPase activity1
negative regulation of locomotion1
negative regulation of cellular process1
regulation of cell motility1
regulation of locomotion1
regulation of cellular process1
protein binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

324 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CCDC125CCDC74BQ96LY2624
CCDC125CFAP184Q2M329614
CCDC125CFAP263Q9H0I3540
CCDC125CCDC70Q6NSX1537
CCDC125CCDC92Q53HC0526
CCDC125C9orf153Q5TBE3514
CCDC125BICDL1Q6ZP65485
CCDC125RASL11BQ9BPW5454
CCDC125TACC1O75410443
CCDC125CCDC169A6NNP5435
CCDC125CCDC190Q86UF4431
CCDC125POLR2BP30876421
CCDC125TLCD2A6NGC4415
CCDC125CCDC42Q96M95412
CCDC125TXNDC15Q96J42408

IntAct

198 interactions, top by confidence:

ABTypeScore
CCDC125ZNF343psi-mi:“MI:0915”(physical association)0.560
CCDC125CDC23psi-mi:“MI:0915”(physical association)0.560
CCDC125OTOSpsi-mi:“MI:0915”(physical association)0.560
ATOSBCCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125FAM161Bpsi-mi:“MI:0915”(physical association)0.560
RAB2ACCDC125psi-mi:“MI:0915”(physical association)0.560
ZNF165CCDC125psi-mi:“MI:0915”(physical association)0.560
NEBLCCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF337psi-mi:“MI:0915”(physical association)0.560
EIF3DCCDC125psi-mi:“MI:0915”(physical association)0.560
TRIM14CCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF837psi-mi:“MI:0915”(physical association)0.560
C21orf58CCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125KAT5psi-mi:“MI:0915”(physical association)0.560
GEMCCDC125psi-mi:“MI:0915”(physical association)0.560
TSGA10IPCCDC125psi-mi:“MI:0915”(physical association)0.560
ZNF792CCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125SPMIP2psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF587psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF764psi-mi:“MI:0915”(physical association)0.560
TEAD4CCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125AIRIMpsi-mi:“MI:0915”(physical association)0.560
CCDC125CEP95psi-mi:“MI:0915”(physical association)0.560
ZNF883CCDC125psi-mi:“MI:0915”(physical association)0.560
CCDC125ZNF564psi-mi:“MI:0915”(physical association)0.560
CDK18CCDC125psi-mi:“MI:0915”(physical association)0.560
MYH1CCDC125psi-mi:“MI:0915”(physical association)0.560
ZFP1CCDC125psi-mi:“MI:0915”(physical association)0.560
NSMFCCDC125psi-mi:“MI:0915”(physical association)0.560

BioGRID (68): CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid), CCDC125 (Two-hybrid)

ESM2 similar proteins: A0A1W2P884, A2AM05, A2AUM9, A2BGP7, E1U8D0, O94964, P60853, Q05D60, Q0KK56, Q2M243, Q32LC2, Q3UPP8, Q3V036, Q5PQQ9, Q5PQS2, Q5R9L2, Q5SZL2, Q5U3Z6, Q5U465, Q5U4W1, Q5XJA2, Q6AXZ4, Q6AYB8, Q6DIS8, Q6IPM2, Q6NRK1, Q6NRX3, Q6P2H3, Q6P402, Q6PCQ0, Q70YC5, Q7M6Y5, Q86YF9, Q86Z20, Q8BG89, Q8BMD2, Q8BMK0, Q8BVC4, Q8CFC9, Q8CGZ2

Diamond homologs: A2BGP7, Q5U465, Q86Z20

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 66 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Activation of BAD and translocation to mitochondria5100.2×7e-08
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex588.4×9e-08
SARS-CoV-1 targets host intracellular signalling and regulatory pathways588.4×9e-08
Activation of BH3-only proteins565.3×3e-07
RHO GTPases activate PKNs541.7×3e-06
Intrinsic Pathway for Apoptosis538.5×4e-06
SARS-CoV-1-host interactions523.1×4e-05
Apoptosis522.1×4e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

88 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance64
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
563075GRCh37/hg19 5q12.3-13.2(chr5:65315606-68755816)x1Likely pathogenic

SpliceAI

3018 predictions. Top by Δscore:

VariantEffectΔscore
5:69282889:CG:Cdonor_gain1.0000
5:69283030:TTAAG:Tacceptor_gain1.0000
5:69283031:TAAG:Tacceptor_gain1.0000
5:69283032:AAG:Aacceptor_gain1.0000
5:69283033:AG:Aacceptor_gain1.0000
5:69283034:GC:Gacceptor_loss1.0000
5:69283035:C:Aacceptor_loss1.0000
5:69283035:C:CCacceptor_gain1.0000
5:69283036:T:Gacceptor_loss1.0000
5:69283038:CA:Cacceptor_gain1.0000
5:69283039:A:ACacceptor_gain1.0000
5:69283039:A:Cacceptor_gain1.0000
5:69283044:C:CTacceptor_gain1.0000
5:69283045:A:Tacceptor_gain1.0000
5:69300123:CAAAA:Cacceptor_gain1.0000
5:69300128:C:CCacceptor_gain1.0000
5:69313878:C:CTacceptor_gain1.0000
5:69320577:CTGT:Cacceptor_gain1.0000
5:69320581:C:CCacceptor_gain1.0000
5:69282888:A:ACdonor_gain0.9900
5:69282888:ACG:Adonor_gain0.9900
5:69282889:C:CCdonor_gain0.9900
5:69282889:CGC:Cdonor_gain0.9900
5:69283042:C:CTacceptor_gain0.9900
5:69292369:T:Cacceptor_gain0.9900
5:69292369:T:TCacceptor_gain0.9900
5:69294794:T:TAdonor_gain0.9900
5:69300008:CTA:Cdonor_loss0.9900
5:69300010:A:AGdonor_loss0.9900
5:69300011:CCTC:Cdonor_loss0.9900

AlphaMissense

3430 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:69292309:G:CF326L0.990
5:69292309:G:TF326L0.990
5:69292311:A:GF326L0.990
5:69282990:G:CS425R0.989
5:69282990:G:TS425R0.989
5:69282992:T:GS425R0.989
5:69292297:A:CF330L0.986
5:69292297:A:TF330L0.986
5:69292299:A:GF330L0.986
5:69292332:C:GA319P0.985
5:69283016:C:GA417P0.983
5:69292314:C:GA325P0.983
5:69294852:A:GC289R0.982
5:69282999:T:AR422S0.981
5:69282999:T:GR422S0.981
5:69294850:A:CC289W0.980
5:69311141:C:GA144P0.980
5:69311179:A:GL131P0.980
5:69282980:C:GA429P0.979
5:69292320:C:GA323P0.979
5:69282982:A:GL428P0.978
5:69294882:A:GC279R0.978
5:69283003:T:GQ421P0.977
5:69283007:G:CH420D0.975
5:69306884:A:GW184R0.975
5:69306884:A:TW184R0.975
5:69311128:A:GL148P0.975
5:69311158:A:GL138P0.975
5:69294880:G:CC279W0.974
5:69292306:T:AR327S0.973

dbSNP variants (sampled 300 via entrez): RS1000025282 (5:69316765 G>A), RS1000066371 (5:69295015 CA>C,CAA), RS1000093550 (5:69334054 G>A,T), RS1000125340 (5:69317172 C>A,T), RS1000221720 (5:69315282 G>A), RS1000270662 (5:69333086 G>T), RS1000308433 (5:69289080 G>A,C), RS1000327476 (5:69308287 C>G), RS1000327949 (5:69300658 A>G), RS1000537827 (5:69288295 A>G), RS1000611255 (5:69290900 G>C), RS1000657960 (5:69334416 A>G), RS1000663079 (5:69302703 G>A), RS1000822759 (5:69296699 T>C), RS1000836867 (5:69334342 G>T)

Disease associations

OMIM: gene MIM:613781 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST004608_13Granulocyte percentage of myeloid white cells3.000000e-12
GCST004610_74White blood cell count3.000000e-12
GCST004613_138Sum neutrophil eosinophil counts4.000000e-15
GCST004614_155Granulocyte count2.000000e-15
GCST004620_151Sum basophil neutrophil counts1.000000e-15
GCST004626_45Myeloid white cell count9.000000e-14
GCST004629_66Neutrophil count2.000000e-15
GCST004633_54Neutrophil percentage of white cells1.000000e-09
GCST90002389_204Lymphocyte percentage of white cells1.000000e-13
GCST90002394_69Monocyte percentage of white cells1.000000e-10
GCST90002398_467Neutrophil count2.000000e-31
GCST90002399_392Neutrophil percentage of white cells9.000000e-20
GCST90002407_458White blood cell count9.000000e-22

EFO canonical traits (8, from GWAS)

EFO IDTrait name
EFO:0007997granulocyte percentage of myeloid white cells
EFO:0004833neutrophil count
EFO:0004842eosinophil count
EFO:0007987granulocyte count
EFO:0005090basophil count
EFO:0007990neutrophil percentage of leukocytes
EFO:0007993lymphocyte percentage of leukocytes
EFO:0007989monocyte percentage of leukocytes

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
potassium chromate(VI)affects cotreatment, decreases expression2
Tobacco Smoke Pollutiondecreases expression2
aristolochic acid Idecreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
beta-lapachoneincreases expression1
aflatoxin B2increases methylation1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
avobenzonedecreases expression1
di-n-butylphosphoric acidaffects expression1
chromium hexavalent iondecreases expression1
CGP 52608affects binding, increases reaction1
ICG 001increases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Temozolomidedecreases expression1
Acetaminophendecreases expression1
Air Pollutantsincreases abundance, increases expression1
Lipopolysaccharidesdecreases expression, affects response to substance, increases expression1
Smokeincreases abundance, increases expression1
Urethanedecreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1increases methylation1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1
Vitamin K 3affects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.